Apogee Therapeutics, Inc.

This study tests whether a new combination of two drugs (APG777 and APG990) is safe and how the body processes them in adults with moderate-to-severe atopic dermatitis (eczema). About 86 participants will receive either the new combo or an existing treatment (dupilumab) for 24 we…

This study tests an experimental drug called APG777 in 470 adults with moderate-to-severe eczema (atopic dermatitis) that hasn't improved with creams. The goal is to see if the drug safely reduces skin redness, itching, and rash. Participants receive either APG777 or a placebo fo…

This study tests a new drug called APG777 in 31 adults with mild-to-moderate asthma. The main goal is to check if the drug is safe and how the body processes it. Participants receive either the drug or a placebo, and researchers monitor for side effects and measure drug levels in…